PW Medtech Group Limited (HKG:1358)
Hong Kong · Delayed Price · Currency is HKD 1.080
0.00 (0.00%)
Jul 10, 2026, 3:59 PM HKT
PW Medtech Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,549 | 1,898 | 1,487 | 1,284 | 986 | 1,569 | |
Market Cap Growth | -13.92% | 27.68% | 15.81% | 30.16% | -37.15% | -53.49% |
Enterprise Value | 566 | 915 | 497 | 524 | 179 | -1,308 |
Last Close Price | 1.08 | 1.27 | 0.91 | 0.69 | 0.50 | 0.79 |
PE Ratio | 15.54 | 18.08 | 9.27 | 7.61 | 8.23 | 1.73 |
Forward PE | - | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 |
PS Ratio | 1.69 | 2.07 | 1.82 | 1.73 | 1.63 | 4.71 |
PB Ratio | 0.29 | 0.35 | 0.29 | 0.24 | 0.19 | 0.34 |
P/TBV Ratio | 0.57 | 0.70 | 0.59 | 0.37 | 0.29 | 0.35 |
P/FCF Ratio | 9.24 | 11.32 | 5.33 | 7.12 | 4.03 | 49.32 |
P/OCF Ratio | 5.78 | 7.09 | 4.39 | 5.52 | 3.24 | 34.33 |
PEG Ratio | - | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 |
EV/Sales Ratio | 0.62 | 1.00 | 0.61 | 0.71 | 0.29 | - |
EV/EBITDA Ratio | 1.92 | 3.13 | 1.62 | 1.72 | 0.90 | - |
EV/EBIT Ratio | 4.05 | 6.54 | 2.69 | 2.66 | 1.61 | - |
EV/FCF Ratio | 3.38 | 5.46 | 1.78 | 2.91 | 0.73 | - |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.08 | 0.08 | 0.04 | 0.00 | 0.02 | 0.03 |
Debt / FCF Ratio | 0.15 | 0.15 | 0.05 | 0.01 | 0.02 | 0.09 |
Net Debt / Equity Ratio | -0.37 | -0.37 | -0.35 | -0.33 | -0.30 | -0.63 |
Net Debt / EBITDA Ratio | -6.79 | -6.79 | -5.80 | -5.77 | -7.88 | -30.90 |
Net Debt / FCF Ratio | -11.85 | -11.85 | -6.39 | -9.73 | -6.38 | -92.94 |
Asset Turnover | 0.16 | 0.16 | 0.15 | 0.13 | 0.12 | 0.06 |
Inventory Turnover | 3.13 | 3.13 | 2.72 | 2.19 | 2.88 | 2.92 |
Quick Ratio | 8.99 | 8.99 | 10.32 | 11.79 | 9.10 | 24.42 |
Current Ratio | 10.89 | 10.89 | 11.80 | 13.61 | 11.59 | 24.82 |
Return on Equity (ROE) | 2.80% | 2.80% | 4.00% | 4.33% | 3.06% | 16.61% |
Return on Assets (ROA) | 1.51% | 1.51% | 2.10% | 2.21% | 1.38% | 0.64% |
Return on Invested Capital (ROIC) | 3.36% | 3.33% | 4.58% | 4.90% | 3.46% | 1.95% |
Return on Capital Employed (ROCE) | 2.50% | 2.50% | 3.50% | 3.60% | 2.00% | 1.20% |
Earnings Yield | 6.78% | 5.53% | 10.79% | 13.15% | 12.15% | 57.82% |
FCF Yield | 10.83% | 8.83% | 18.75% | 14.05% | 24.84% | 2.03% |
Dividend Yield | 5.93% | 5.05% | 10.72% | 14.38% | - | - |
Payout Ratio | 92.08% | 138.13% | 89.11% | 46.74% | - | 279.01% |
Buyback Yield / Dilution | 2.11% | 2.11% | 1.42% | 0.03% | 0.20% | 0.00% |
Total Shareholder Return | 8.04% | 7.16% | 12.13% | 14.41% | 0.20% | 0.00% |